JP2024541616A - 造血幹細胞を維持する、および拡大増殖させるための、方法および組成物 - Google Patents

造血幹細胞を維持する、および拡大増殖させるための、方法および組成物 Download PDF

Info

Publication number
JP2024541616A
JP2024541616A JP2024532440A JP2024532440A JP2024541616A JP 2024541616 A JP2024541616 A JP 2024541616A JP 2024532440 A JP2024532440 A JP 2024532440A JP 2024532440 A JP2024532440 A JP 2024532440A JP 2024541616 A JP2024541616 A JP 2024541616A
Authority
JP
Japan
Prior art keywords
agonist
hscs
culture medium
present
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024532440A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024541616A5 (https=
Inventor
ウェルチー アンゼリカ エム． ゴームズ
Original Assignee
トレイルヘッド バイオシステムズ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by トレイルヘッド バイオシステムズ インコーポレイテッド filed Critical トレイルヘッド バイオシステムズ インコーポレイテッド
Publication of JP2024541616A publication Critical patent/JP2024541616A/ja
Publication of JP2024541616A5 publication Critical patent/JP2024541616A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/42—Organic phosphate, e.g. beta glycerophosphate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/42—Notch; Delta; Jagged; Serrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
JP2024532440A 2021-11-30 2022-11-29 造血幹細胞を維持する、および拡大増殖させるための、方法および組成物 Pending JP2024541616A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163284360P 2021-11-30 2021-11-30
US63/284,360 2021-11-30
PCT/US2022/051195 WO2023101943A1 (en) 2021-11-30 2022-11-29 Methods and compositions for maintaining and expanding hematopoietic stem cells

Publications (2)

Publication Number Publication Date
JP2024541616A true JP2024541616A (ja) 2024-11-08
JP2024541616A5 JP2024541616A5 (https=) 2025-12-05

Family

ID=84901401

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024532440A Pending JP2024541616A (ja) 2021-11-30 2022-11-29 造血幹細胞を維持する、および拡大増殖させるための、方法および組成物

Country Status (9)

Country Link
US (1) US20230167408A1 (https=)
EP (1) EP4441205A1 (https=)
JP (1) JP2024541616A (https=)
KR (1) KR20240110653A (https=)
CN (1) CN118302519A (https=)
AU (1) AU2022399413A1 (https=)
CA (1) CA3238518A1 (https=)
IL (1) IL312661A (https=)
WO (1) WO2023101943A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025080674A1 (en) 2023-10-09 2025-04-17 Trailhead Biosystems Inc. Methods to improve enduring hematopoietic stem cell transplantation
WO2025129033A1 (en) * 2023-12-14 2025-06-19 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for hematopoietic stem and progenitor cell expansion

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2488425A1 (en) * 2002-06-07 2003-12-18 Es Cell International Pte Ltd Methods of regulating differentiation in stem cells
CA2948871A1 (en) * 2014-05-22 2015-11-26 Fred Hutchinson Cancer Research Center Lilrb2 and notch-mediated expansion of hematopoietic precursor cells
US10669528B2 (en) * 2015-06-25 2020-06-02 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
EP4049665B1 (en) * 2016-03-15 2025-03-12 The Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion
US20180163177A1 (en) * 2016-12-11 2018-06-14 Healthbanks Biotech Co. Ltd. Serum-free culture medium and method for expanding hematopoietic stem cells
GB201706544D0 (en) * 2017-04-25 2017-06-07 Plasticell Ltd Method
CN114286860A (zh) * 2019-08-29 2022-04-05 味之素株式会社 由含有间充质干细胞的生物来源细胞试样制造间充质干细胞的方法

Also Published As

Publication number Publication date
IL312661A (en) 2024-07-01
CN118302519A (zh) 2024-07-05
WO2023101943A1 (en) 2023-06-08
KR20240110653A (ko) 2024-07-15
AU2022399413A1 (en) 2024-05-23
EP4441205A1 (en) 2024-10-09
US20230167408A1 (en) 2023-06-01
CA3238518A1 (en) 2023-06-08

Similar Documents

Publication Publication Date Title
Lauridsen et al. Differences in cell cycle status underlie transcriptional heterogeneity in the HSC compartment
JP2024163197A (ja) ヒト多能性幹細胞からの心房および心室心筋細胞系列の生成
JP2020124212A (ja) ヒト造血幹／前駆細胞のエクスビボ拡大のための組成物および方法
US20130136722A1 (en) Methods of Ex Vivo Expansion of Blood Progenitor Cells, and Generation of Composite Grafts
US20230167408A1 (en) Methods and compositions for maintaining and expanding hematopoietic stem cells
Adamiak et al. The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing—a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking
Lin et al. Graft-versus-host disease causes broad suppression of hematopoietic primitive cells and blocks megakaryocyte differentiation in a murine model
JP2023504424A (ja) 代謝は内皮から造血への移行中の決定的系統指定を誘導する
Gao et al. Tetrahydroxy stilbene glucoside rejuvenates aging hematopoietic stem cells with predilection for lymphoid differentiation via AMPK and Tet2
Migliaccio et al. Under HEMA conditions, self-replication of human erythroblasts is limited by autophagic death
Sinha et al. iNOS regulates hematopoietic stem and progenitor cells via mitochondrial signaling and is critical for bone marrow regeneration
Tatetsu et al. Maintenance and enhancement of human peripheral blood mobilized stem/progenitor cell engraftment after ex vivo culture via an HDACi/SALL4 axis (3465)
Shin et al. The Gata1low murine megakaryocyte–erythroid progenitor cells expand robustly and alter differentiation potential
EP3452581B1 (en) 4hpr and its use in the culturing of hematopoietic stem cells
CN118382694A (zh) 产生人红系祖细胞的方法和组合物
Keyvani Chahi CHARACTERIZING THE ROLE OF THE TRANSCRIPTION FACTOR PLAG1 IN HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS
Poscablo Alterations to Platelet Differentiation Pathways Arising From Hematopoietic Stem Cells During Aging
Sousae Methylation of histone H3 lysine-9 regulates hematopoietic stem cell differentiation
Chen Regulation of human hematopoietic stem cell lineage commitment
Pirsavabi et al. Ex vivo culture of hematopoietic stem and progenitor cells with platelet lysate: Investigating proliferation and erythroid-megakaryocytic lineage effects
Arede Novel roles of KAT2A chromatin complexes ATAC and SAGA in normal and malignant haematopoiesis
WO2025080674A1 (en) Methods to improve enduring hematopoietic stem cell transplantation
Marcoux RET-altered Induced Pluripotent Stem Cells (iPSCs) for modeling Hematopoiesis and Non-Small Cell Lung Cancer (NSCLC)
Ho Aging and autophagy in hematopoietic stem cells
Nguyen-McCarty Characterizing A Signaling Network That Maintains Hematopoietic Stem Cells

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241008

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251127

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251127